20.52
-0.22(-1.06%)
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
40557
First IPO Date
October 30, 2012
| Name | Title | Pay | Year Born |
| Wang Xingli | Co-President, CEO of Innovative Medicines Div., Chairman of Global R&D Center | 0 | 1962 |
| Wenjie Zhang | Co-President & Co-CEO of Innovative Medicines Division | 0 | 1967 |
| Jing Li | Co-President and Chief Executive Officer of Established Medicines Manufacturing & Supply Division | 0 | 1972 |
| Yi Liu | President, CEO, Chairman, CEO of Medical Devices Division & Executive Director | 0 | 1975 |
| Yuqing Chen | Executive Chairman | 0 | 1975 |
| Zhanyu Chen | Senior Vice President & Chief Financial Officer | 0 | N/A |
| Rongli Feng | Executive President & Chief Human Resources Officer | 0 | 1975 |
| Donghua Wang | Senior Vice President | 0 | 1969 |
| Kexin Wang | Executive Director | 0 | 1964 |
| Xiaohui Guan | Executive Co-Chairman | 0 | 1971 |
| Yue Zhu | VP & GM of Legal Department | 0 | 1977 |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
